Article

Evaluating Total Ankle Arthroplasty Candidates and Risks

Take caution when selecting total ankle arthroplasty candidates.

Researchers from Thomas Jefferson University Medical College recommend that caution be taken when selecting and educating patients with arthritic conditions about total ankle arthroplasty.

The team performed a retrospective chart review of 106 total ankle arthroplasties and published their findings in the The Journal of Bone and Joint Surgery (American).

The team sought to evaluate previous data from surgeries to evaluate the possible risk factors for developing wound complications. They examined independent risk variables, including: age, sex, body-mass index, diabetes, smoking, medications, preoperative diagnosis, implant size, tourniquet time, closure method, and anticoagulation status.

Post-operative notes were also examined. The outcomes were divided into three categories: no complications, minor complications, and major complications.

The team found that when patients with no complications were compared with those who had minor complications, a history of diabetes was the only variable identified as resulting in a significant increase. Next, they compared patients with no complications or minor wound complications to those with major complications. They found that the female sex, a history of corticoid steroid use, and underlying inflammatory arthritis were all associated with increased risk.

Additionally, the researchers found that underlying inflammatory arthritis was the only significant risk factor for major wound complications.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.